The table below shows Aclaris Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$2.00M
$3.30M
$1.78M
$1.46M
$4.35M
$2.77M
Cost of revenue
$395.00K
$538.00K
$515.00K
$506.00K
$654.00K
$624.00K
Gross profit
-
-
-
-
-
-
R&D
$15.66M
$13.03M
$11.45M
$11.58M
$5.96M
$8.76M
ACRS annual revenue (10-K history)
Aclaris Therapeutics, Inc. reported annual revenue of $7.83M for fiscal year 2025. That is down 58.2% from $18.72M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $1.68M (FY 2017) to $7.83M. Figures come from the company's audited annual reports as filed with the SEC.